Using the p53-null SaOS-2 osteosarcoma cell line, Ganjavi et al. [31] showed that adenoviral-mediated gene transfer of wild-type p53 resulted in reduced cell viability and increased sensitivity to chemotherapeutic agents. This evidence concerns the gene TP53 and osteosarcoma.